RYBELSUS
RYBELSUS
Approved
DIN Number
02497603
Drug Class
Human
Market Date
Apr 19, 2020
Company
HC
Novo Nordisk Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02497603
AIG Number0159870004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
A10BJ06 SEMAGLUTIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.06
Health Canada Classification
ACTIVE INGREDIENTS (1)
SEMAGLUTIDEActive
Strength: 7 MG
Monograph: SEMAGLUTIDE